Literature DB >> 7689268

Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.

O Odocha1, J McCauley, V Scantlebury, R Shapiro, P Carroll, M Jordan, C Vivas, J J Fung, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7689268      PMCID： PMC2981169     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  8 in total

1.  FACTORS IN SUCCESSFUL RENAL TRANSPLANTATION.

Authors:  T E STARZL; T L MARCHIORO; D RIFKIND; J H HOLMES; D T ROWLANDS; W R WADDELL
Journal:  Surgery       Date:  1964-07       Impact factor: 3.982

Review 2.  FK 506: historical perspectives.

Authors:  T Goto; T Kino; H Hatanaka; M Okuhara; M Kohsaka; H Aoki; H Imanaka
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.

Authors:  V Scantlebury; R Shapiro; J Fung; A Tzakis; J McCauley; M Jordan; C Jensen; T Hakala; R Simmons; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 4.  Adverse effects associated with the use of FK 506.

Authors:  J J Fung; M Alessiani; K Abu-Elmagd; S Todo; R Shapiro; A Tzakis; D Van Thiel; J Armitage; A Jain; J McCauley
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.

Authors:  P B Carroll; H Rilo; J Reyes; R Alejandro; Y Zeng; C Ricordi; A Tzakis; R Shapiro; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis.

Authors:  J O Ruiz; R L Simmons; C O Callender; C M Kjellstrand; T J Buselmeier; J S Najarian
Journal:  Surgery       Date:  1973-05       Impact factor: 3.982

7.  The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.

Authors:  J P Boudreaux; L McHugh; D M Canafax; N Ascher; D E Sutherland; W Payne; R L Simmons; J S Najarian; D S Fryd
Journal:  Transplantation       Date:  1987-09       Impact factor: 4.939

8.  Retrospective analysis of posttransplantation diabetes mellitus in black renal allograft recipients.

Authors:  N B Sumrani; V Delaney; P Daskalakis; R Davis; E A Friedman; J H Hong; B G Sommer
Journal:  Diabetes Care       Date:  1991-08       Impact factor: 19.112
  8 in total
  4 in total

1.  Steroid induced diabetes mellitus in patients receiving prednisolone for haematological disorders.

Authors:  T R Kotila; T Olutogun; A Ipadeola
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

2.  Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells.

Authors:  J B Redmon; L K Olson; M B Armstrong; M J Greene; R P Robertson
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

3.  High-throughput screening of one-bead-one-compound libraries: identification of cyclic peptidyl inhibitors against calcineurin/NFAT interaction.

Authors:  Tao Liu; Ziqing Qian; Qing Xiao; Dehua Pei
Journal:  ACS Comb Sci       Date:  2011-08-26       Impact factor: 3.784

4.  Calcineurin/NFATc2 and PI3K/AKT signaling maintains β-cell identity and function during metabolic and inflammatory stress.

Authors:  Carly M Darden; Srividya Vasu; Jordan Mattke; Yang Liu; Christopher J Rhodes; Bashoo Naziruddin; Michael C Lawrence
Journal:  iScience       Date:  2022-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.